Objectives: Anxiety and depression are internalizing mental disorders often commencing in childhood and manifesting in adolescence. The Revised Anxiety and Depression Scale (RCADS) is an internationally widely used standardized diagnostic tool, but the German version has only been validated in a pediatric chronic pain sample; normative data are not available. The aim of this study is to test its reliability (internal consistency) and validity (factorial, convergent, known‐groups) in a representative German school sample and to provide norm data.Methods: Data were collected from N = 1562 German schoolchildren (Mage = 12.2; SDage = 2.33; range 8–17 years; 52.4% girls).Results: Cronbach's α ranged from 0.73 to 0.96 for the total and the six subscales (five anxiety and one depression). Confirmatory factor analysis showed the 6‐factor model had acceptable to good model fit with CFI = 0.93, TLI = 0.93, RMSEA = 0.05, SRMR = 0.05, which was better than 1‐ and 2‐factor models. The (sub)scales correlated moderate to high negatively with health‐related quality of life (−0.31 ≤ τ ≤ −0.51; p < 0.001) and positively with functional impairment (0.31 ≤ τ ≤ 0.48; p < 0.001). Mean scores of anxiety and depression scales were significantly higher in girls and partly in adolescents.Conclusion: Findings provide support for the good psychometric properties of the German RCADS in a community sample.
In this study, we describe the development and validation of a revised Pediatric Chronic Pain Grading (P-CPG) for children aged 8 to 17 years that adds emotional impairment to previously used measures of pain intensity and functional impairment. Such a measure enables the assessment of chronic pain severity in different epidemiological and clinical populations, the stratification of treatment according to pain severity, and the monitoring of treatment outcome. The P-CPG was developed using a representative sample of school children with chronic pain (n = 454; Mage = 12.95, SD = 2.22). Construct validity and sensitivity to change were examined within a sample of N = 2448 children and adolescents (Mage = 12.71, SD = 2.47) comprising 3 subsamples (school n = 1562, primary care n = 129, and tertiary care n = 757) affected by chronic pain to varying extents. Results showed that P-CPG grades differed significantly among the 3 subsamples, with school children being least affected by chronic pain and tertiary care patients being most affected. As P-CPG grade increased, so did pain intensity, functional impairment, pain-related school absence, and emotional impairment. Convergent validity was demonstrated by significant positive correlations between the P-CPG and global ratings of pain severity as well as objective claims data; the latter reflects greater health care costs with increasing P-CPG scores. Sensitivity to change was supported by a significant reduction in baseline P-CPG grades 3 and 6 months after intensive interdisciplinary pain treatment in tertiary care sample. In conclusion, the P-CPG is an appropriate measure of pain severity in children and adolescents with chronic pain in clinical as well as epidemiological settings.
The Pain Stages of Change Questionnaire (PSOCQ) measures patients’ willingness to engage in active self-management of their pain. The present study aimed to create validated German short versions of the PSOCQ for adolescents (PSOCQ-A) and their parents (PSOCQ-P). Additionally, an investigation of stages of change regarding pain characteristics and treatment outcomes was undertaken. In Study 1, the data of adolescents aged 11 to 18 years and their parents were collected prior to intake (N = 501) and at admission (N = 240) to specialist inpatient pain treatment. Confirmatory factor analyses indicated a poor fit of the full PSOCQ measures prior to intake, but an acceptable fit at admission. Short PSOCQ-A and PSOCQ-P versions were identified. In Study 2, these results were cross-validated with data from an additional N = 150 patients and their parents, collected during and 3 months after interdisciplinary inpatient pain treatment. Model fits for both short versions were acceptable, although low internal consistency for the PSOCQ-A Precontemplation and Contemplation subscales was identified. During treatment, both patients’ and their parents’ readiness to change increased. Stage of change at discharge did not predict treatment non-response 3 months later. This study indicates that the PSOCQ is neither meaningful prior to admission nor predictive of non-response to treatment. While some value may exist in monitoring treatment progress, based on the results of this study, it is not recommended that the PSOCQ-A and PSOCQ-P be used as a measure of stage of change in German pediatric pain populations.
26 April 2025 in International Journal of Methods in Psychiatric Research
Objectives: This study assesses the reliability and validity of two short forms of the German Revised Children’s Anxiety and Depression Scale (RCADS 11‐ and 25‐item versions) and provides normative data. Methods: Data were collected from a representative sample of N = 1562 German schoolchildren and N = 757 pediatric chronic pain patients (ages 8–17). Results: Cronbach's α demonstrated acceptable to good internal consistency for the total score as well as the depression and anxiety scales. Confirmatory factor analysis (CFA) demonstrated acceptable to good model fit for both a 2‐factor structure (RCADS‐11) and a higher‐order structure (RCADS‐25). Multi‐group CFAs demonstrated similar model structures across the school and pediatric chronic pain samples. Convergent validity was supported by moderate to high negative correlations with health‐related quality of life and a high positive correlation with functional impairment. Girls—and to some extent, adolescents – scored significantly higher on anxiety and depression scales. The short versions demonstrated excellent agreement with the original 47‐item RCADS (0.78 ≤ Cohen’s κ ≤ 1.0). German normative data are provided. Conclusion: The short versions of the German RCADS are reliable and valid instruments for assessing anxiety and depressive symptoms in children and adolescents.